Zhengye Biotechnology Holding Limited’s (NASDAQ:ZYBT) Lock-Up Period Will End on July 7th

Zhengye Biotechnology’s (NASDAQ:ZYBT) lock-up period will expire on Monday, July 7th. Zhengye Biotechnology had issued 1,500,000 shares in its public offering on January 7th. The total size of the offering was $6,000,000 based on an initial share price of $4.00. After the expiration of the company’s lock-up period, restrictions preventing major shareholders and company insiders from selling shares in the company will be lifted.

Zhengye Biotechnology Stock Down 6.2%

Shares of Zhengye Biotechnology stock opened at $6.61 on Monday. The company’s 50 day simple moving average is $8.71. Zhengye Biotechnology has a 52 week low of $3.50 and a 52 week high of $14.30.

About Zhengye Biotechnology

Zhengye Biotechnology Holding Limited is a veterinary vaccine manufacturer which encompasses research, development, manufacturing and sales of veterinary vaccines, with a focus on livestock vaccine principally in China. Zhengye Biotechnology Holding Limited is based in Jilin, China.